Don't Just Read the News, Understand It.
Get Started
SubscribeLogin
Israel-Hamas Conflict
Social Media
Heatwaves
Donald Trump
World Cup
Artificial Intelligence
Cryptocurrency
Stock Markets
NATO
Immigration
Formula 1
Instagram
Crime
Published • loading... • Updated

Verve Therapeutics' (VERV) Market Perform Rating Reiterated at William Blair

Summary by marketbeat.com
William Blair reissued a "market perform" rating on shares of Verve Therapeutics in a research report on Tuesday.

3 Articles

All
Left
Center
2
Right
marketbeat.commarketbeat.com
Center

Verve Therapeutics' (VERV) Market Perform Rating Reiterated at William Blair

William Blair reissued a "market perform" rating on shares of Verve Therapeutics in a research report on Tuesday.

Read Full Article
CNBCCNBC
Reposted by
franktrades.comfranktrades.com
Center

Stocks making the biggest moves premarket: Sunrun, Verve Therapeutics, T-Mobile and more

These are the stocks posting the largest moves in premarket trading.

·United States
Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 100% of the sources are Center
100% Center
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

CNBC broke the news in United States on Tuesday, June 17, 2025.
Sources are mostly out of (0)

Similar News Topics

Bill Blair icon

Bill Blair

Stock Markets icon

Stock Markets

You have read 1 out of your 5 free daily articles.

Join millions of well-informed readers who use Ground to compare coverage, check their news blindspots, and challenge their worldview.

News
For You
SearchBlindspotLocal